P2P Intervention, Standard of Care
Conditions
Brief summary
This study provides substance use and mental health peer support services to address behavioral health disparities in rural areas. Specifically, the project aims to address persistent mental health symptoms, such as anxiety and depression, that become barriers to care for patients working towards long-term recovery from co-occurring mental health and substance use disorders. Participants will be assessed and evaluated for opioid use disorder (OUD), social determinants of health (SDoH), and infectious diseases by a nurse practitioner and a social worker. A certified peer support specialist (CPSS) will provide additional support, connecting patients to sustainable mental health resources and implementing a modified version of the Friendship Bench intervention, which involves six weekly 45-minute problem-solving therapy sessions with the option to participate in six or more peer support sessions. The CPSS will follow the patient for up to 12 weeks.
Interventions
BEHAVIORALP2P Intervention
This group will complete the same study visits as the standard care group with an additional week 3 visit and 6 CPSS-led therapy intervention sessions. These CPSS led sessions will be completed by the end of the 12week study period. At each study visit you will complete questionnaires.
Sponsors
Prisma Health-Upstate
South Carolina Center for Rural and Primary Healthcare
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of OUD via Diagnostic Statistical Manual (DSM)-V Text Revision (TR) * Receiving MOUD through the Mobile Recovery Program for at least 3 months * Age 18 or older * Moderate to Severe Depression with or without co-occurring anxiety as determined by PHQ-9 conducted during the most recent MRP clinical visit
Exclusion criteria
* Severe cognitive, medical, or psychiatric disability that could impair ability to perform study-related activities as determined by the MRP clinician or principal investigator. * Unable to read/speak English * Unable to read and comprehend the consent materials and other study materials * Current suicidal ideation based on the Patient Health Questionnaire-9
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in depressive symptoms | 12 weeks | Reduce depression symptoms as measured by the PHQ-9 |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORAlain Litwin
Prisma Health
Outcome results
None listed